Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of ruthenium-artesunate complex and its preparation method and application

A technology of artesunate and complexes, which are applied in the field of ruthenium-artesunate complexes and their preparation methods and their antitumor effects, can solve the problems of poor water solubility, low bioavailability and limited application of artesunate tablets. and other problems, to achieve good anti-tumor activity and increase the effect of intake

Active Publication Date: 2022-03-18
KUNMING UNIV OF SCI & TECH
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, artesunate tablets have poor water solubility, and oral administration has obvious first-pass effect and hepatic drug enzyme induction, and the bioavailability is low; and artesunate powder injection blood concentration drops quickly after intravenous injection, and the half-life is only About 30 minutes, the clearance rate in the body is fast, the above shortcomings limit its application in many diseases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of ruthenium-artesunate complex and its preparation method and application
  • A kind of ruthenium-artesunate complex and its preparation method and application
  • A kind of ruthenium-artesunate complex and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] 7.6729mmol DIP, 3.836mmol RuCl 3 ·nH 2 O and 38.36mmol lithium chloride were placed in a three-necked flask, and 11mL of N,N-dimethylformamide was added, and reacted at 153°C for 8h under nitrogen protection. After the reaction was completed, the reaction solution was added dropwise to 150mL of ice acetone, , placed in a 4°C refrigerator overnight, suction filtered, and washed alternately with 4°C pre-cooled water and acetone to obtain cis-[Ru(DIP) 2 Cl 2 ]·2H 2 O;

[0032] Take 0.3144mmol cis-[Ru(DIP) 2 Cl 2 ]·2H 2O and 0.3144mmol 4-hydroxymethyl-4'-methyl-2-2'-bipyridine were placed in a three-necked flask, and 100mL of ethanol aqueous solution with a volume fraction of 75% was added, and reacted at 85°C for 8h under nitrogen protection, and the reaction was completed Afterwards, the reaction solution was fully concentrated to 10 mL, and 1.2576 mmol of ammonium hexafluorophosphate solid was added, and a large amount of precipitate was precipitated by ultrasonic...

Embodiment 2

[0037] Experimental test for antitumor activity of ruthenium-artesunate complex:

[0038] HepG2, A549R, and HeLa cells were respectively treated with DMEM medium containing 10% fetal bovine serum and 1% penicillin-streptomycin solution (10% fetal bovine serum and 1% penicillin-streptomycin were volume percentages), at 37°C , 5% CO 2 Cultured in a cell incubator, the cells were digested with 0.25% trypsin by mass percentage into a single cell suspension, and the viable cells were counted with a hemocytometer, and the concentration of viable cells was adjusted to 5×10 4 / mL was inoculated in 96-well culture plate, 160 μL per well, and after 24 hours of culture, different amounts of drugs were added respectively. °C, with 5% CO 2 Incubate in an incubator for 48 hours, add MTT (20 μL / well) 4 hours before the end, discard the supernatant after 4 hours, add DMSO (150 μL / well), shake for 15 minutes, and then measure the absorbance at a wavelength of 570 nm.

[0039] The cells were...

Embodiment 3

[0046] The uptake of ruthenium-artesunate complexes in HeLa cells was studied. In this example, the uptake of ruthenium-artesunate complexes in HeLa cells was observed by laser confocal microscopy:

[0047] HeLa cells were cultured in a 35mm Corning laser confocal culture dish. When the density was 70%, 5μM Ru-2 was added to incubate for 1h, 2h, 3h, and 4h respectively. After that, they were washed twice with PBS, and immediately washed with laser light. Confocal microscope observation.

[0048] Research results such as Figure 5 As shown, the uptake of Ru-2 by cells increased in a time-dependent manner.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a ruthenium-artesunate complex and its preparation method and application. The ruthenium-artesunate complex can use the ruthenium complex to improve the uptake of artesunate by cells. After entering the cells, the ruthenium complex can Synergize with artesunate to play an anti-tumor effect. The present invention studies the anti-tumor activity of ruthenium-artesunate complexes and finds that it has good anti-tumor activity. Compared with traditional small organic molecules, ruthenium complexes have In the multi-coordinate configuration, different ligands can be modified to achieve specific binding to the corresponding substrate.

Description

technical field [0001] The invention relates to a ruthenium-artesunate complex and its preparation method and its antitumor effect, belonging to the field of chemical biology. Background technique [0002] The ruthenium complex has a 6-coordinated octahedral configuration, and its unique three-dimensional structure can provide a variety of coordination modes, so it can better match the three-dimensional structure cavity of the protein and improve the selectivity of the metal complex to the protein; ruthenium Polypyridine complexes also have rich photochemical and photophysical properties, which can facilitate cell localization and mechanism studies. In 1980, Clarke et al. discovered the complex Cl(NH 3 ) 5 Ru(III) has anticancer activity against tumor-bearing rats. Zassinovich et al found that cis-[RuCl containing DMSO ligand 2 (DMSO) 4 ] has activity on mouse lung cancer cells, its activity is slightly weaker than cisplatin, but its side effects are less. At present, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07F15/00A61P35/00
Inventor 李蓉涛陈毕纯叶瑞绒刘丹陈宣钦李洪梅卢俊健马秀蓉
Owner KUNMING UNIV OF SCI & TECH